Gossamer Bio (GOSS) News Today $2.36 +0.02 (+0.85%) Closing price 04:00 PM EasternExtended Trading$2.39 +0.03 (+1.44%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GOSS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS)August 19, 2025 | finance.yahoo.comAnalysts' Revenue Estimates For Gossamer Bio, Inc. (NASDAQ:GOSS) Are Surging HigherAugust 15, 2025 | finance.yahoo.comGossamer Bio Reports Q2 2025 Financial ResultsAugust 12, 2025 | msn.comInstitutional investors in Gossamer Bio, Inc. (NASDAQ:GOSS) see US$54m decrease in market cap last week, although long-term gains have benefitted them.August 11, 2025 | finance.yahoo.comQ3 EPS Estimates for Gossamer Bio Increased by HC WainwrightAugust 11, 2025 | marketbeat.comWedbush Has Optimistic Outlook of Gossamer Bio Q3 EarningsAugust 11, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Stock Rating Lowered by Wall Street ZenAugust 10, 2025 | marketbeat.comLeerink Partners Sticks to Its Buy Rating for Gossamer Bio (GOSS)August 9, 2025 | theglobeandmail.comQ3 EPS Estimates for Gossamer Bio Reduced by Leerink PartnrsAugust 9, 2025 | marketbeat.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 7, 2025 | businesswire.comWedbush Boosts Gossamer Bio (NASDAQ:GOSS) Price Target to $5.00August 7, 2025 | marketbeat.comFY2025 EPS Estimates for Gossamer Bio Boosted by AnalystAugust 7, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Issues Earnings Results, Beats Expectations By $0.01 EPSAugust 6, 2025 | marketbeat.comGossamer Bio (GOSS) Expected to Announce Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comGossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by GSA Capital Partners LLPAugust 3, 2025 | marketbeat.comScotiabank Initiates Outperform on Gossamer Bio (GOSS) with an $11 PT, Highlights Potential of PAH Drug SeralutinibAugust 1, 2025 | insidermonkey.comInvestors Purchase High Volume of Call Options on Gossamer Bio (NASDAQ:GOSS)July 30, 2025 | marketbeat.comMonaco Asset Management SAM Reduces Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS)July 30, 2025 | marketbeat.comScotiabank Initiates Coverage of Gossamer Bio (GOSS) with Sector Outperform RecommendationJuly 14, 2025 | msn.comGossamer Bio (NASDAQ:GOSS) Now Covered by Analysts at ScotiabankJuly 14, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Shares Down 3.2% - Time to Sell?July 3, 2025 | marketbeat.comGOSS | Gossamer Bio Inc. Annual Income Statement - MarketWatchJune 26, 2025 | marketwatch.comGossamer Bio Completes Enrollment for Phase 3 PROSERA Study of PAH Drug SeralutinibJune 24, 2025 | msn.comGossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAHJune 16, 2025 | businesswire.comCantor Fitzgerald Comments on Gossamer Bio FY2026 EarningsJune 10, 2025 | marketbeat.comTwo Sigma Investments LP Raises Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)June 8, 2025 | marketbeat.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | businesswire.comMackenzie Financial Corp Has $271,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)June 5, 2025 | marketbeat.comTwo Sigma Advisers LP Grows Position in Gossamer Bio, Inc. (NASDAQ:GOSS)June 1, 2025 | marketbeat.comMillennium Management LLC Has $3.24 Million Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)June 1, 2025 | marketbeat.comHC Wainwright Increases Earnings Estimates for Gossamer BioMay 27, 2025 | marketbeat.comCantor Fitzgerald Comments on Gossamer Bio FY2025 EarningsMay 23, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)May 21, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Cuts Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)May 19, 2025 | marketbeat.comEarnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecastsMay 17, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Gossamer Bio stockMay 17, 2025 | uk.investing.comGOSSAMER BIO Earnings Results: $GOSS Reports Quarterly EarningsMay 17, 2025 | nasdaq.comGossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comQ1 2025 Gossamer Bio Inc Earnings CallMay 16, 2025 | finance.yahoo.comGossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ...May 16, 2025 | finance.yahoo.comGossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comGossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA StudyMay 15, 2025 | businesswire.comGossamer Bio, Inc. (NASDAQ:GOSS) Shares Bought by Octagon Capital Advisors LPMay 15, 2025 | marketbeat.comAlyeska Investment Group L.P. Purchases 3,041,058 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)May 8, 2025 | marketbeat.comGossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International ConferenceMay 7, 2025 | finance.yahoo.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 7, 2025 | businesswire.comAllostery Investments LP Invests $555,000 in Gossamer Bio, Inc. (NASDAQ:GOSS)May 4, 2025 | marketbeat.comGossamer Bio: Initiating Hold As Late‐Stage Data Nears InflectionMay 2, 2025 | seekingalpha.comGossamer Bio (GOSS) to Release Earnings on TuesdayMay 1, 2025 | marketbeat.comMarshall Wace LLP Sells 950,554 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)April 29, 2025 | marketbeat.com Get Gossamer Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter. Email Address GOSS Media Mentions By Week GOSS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOSS News Sentiment▼0.000.70▲Average Medical News Sentiment GOSS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOSS Articles This Week▼12▲GOSS Articles Average Week Get Gossamer Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DYN News Today BEAM News Today APGE News Today BHVN News Today TWST News Today TVTX News Today IMCR News Today AUPH News Today CDTX News Today WVE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOSS) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access